EU Regulatory Panel Recommends Approval Of Glaxo's Gene Therapy For Bubble Boy Disease

An EU panel has recommended the approval of a Glaxo gene therapy that aims to treat Bubble Boy Disease. The treatment gives hope to patients with the rare disorder, which does not currently have a medicinal treatment.